Table 2.
Methodological item for nonrandomised studies | Ghahreman et al. | Wang et al. | Archavlis and Carvi y Nievas | Kotani et al. | Parker et al. |
---|---|---|---|---|---|
(1) A clearly stated aim | 2 | 2 | 2 | 2 | 2 |
(2) Inclusion of consecutive patients | 1 | 2 | 2 | 1 | 1 |
(3) Prospective collection of data | 2 | 2 | 2 | 2 | 2 |
(4) Endpoints appropriate to the aim of the study | 2 | 2 | 2 | 2 | 2 |
(5) Unbiased assessment of the study end point | 0 | 0 | 0 | 0 | 0 |
(6) Follow-up period appropriate to the aim of the study | 1 | 1 | 2 | 2 | 2 |
(7) Loss to follow-up less than 5% | 2 | 2 | 2 | 2 | 2 |
(8) Prospective calculation of the study size | 0 | 0 | 0 | 0 | 0 |
(9) An adequate control group | 2 | 2 | 2 | 2 | 2 |
(10) Contemporary groups | 2 | 2 | 2 | 2 | 2 |
(11) Baseline equivalence of groups | 2 | 2 | 2 | 2 | 2 |
(12) Adequate statistical analyses | 2 | 2 | 2 | 2 | 2 |
Total scores | 18 | 19 | 20 | 19 | 19 |